Lantern Pharma Announces Upcoming Conference Presentations
- Thursday, August 27, 2020, 7:08
- Finance
- Add a comment
DALLAS, Aug. 27, 2020 /PRNewswire/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug discovery and development, and identify patients who…
About the Author
adminasapcorp has written 39604 stories on this site.